Intelligence

Search filters

Digital revolution: what the Topol Review means for NHS senior leadership

SJ Leatherdale, Partner and Head of our Health and Life Sciences Practice explains how the Topol Review will impact senior leadership across NHS Trusts and bodies

Life Sciences businesses engage interim managers to navigate industry turbulence

Fledgling businesses in the life sciences sector have long struggled with the financial demands that are needed to survive extensive trial periods and secure regulatory approval for their first pharmaceutical product. But now,...

Life Sciences look to interims to deliver ambitions

We look at specialist roles emerging in the Life Sciences sector as the Brexit vote challenges the industry's growth ambitions.

Innovation: the true spirit of Life Sciences

Some companies change the world. Today that mission is as clear for the likes of Tesla and Google as it was generations ago for Ford or General Electric.

Healthtech: Technology & Healthcare

Nick Behan, Consultant in Odgers Interim’s Life Science team, discusses Healthtech: Technology & Healthcare.

The status quo and trends in life sciences

The “new normal” of expiring patents, shrinking pipelines, fewer billion dollar blockbusters, generic competition, pricing pressures, increased regulatory scrutiny and the economic downturn has seen a significant drop in sales and...

Guest interview with Thomas Gageik, a specialist in IT

Perspective talks to Thomas Gageik...

Guest Interview with Geoff Tompsett, Head of Human Resources at Daiichi Sankyo Development Ltd

Perspective talks to Geoff Tompsett - Head of Human Resources at Daiichi Sankyo Development Ltd…

You are currently offline. Some pages or content may fail to load.